Indication: Lymphoma in Companion Animals
Title: Phase II Study of the Oral Selective Inhibitor of Nuclear Export (SINE) KPT-335 (verdinexor) in Dogs with Lymphoma.
Drug: verdinexor

Rights

Drug: verdinexor

PreclinicalPhase IPhase IIPhase III
Preclinical
Phase I
Phase II
Phase III